Executive Summary: The Emerging HPV Therapeutic Gel Market The global vaginal gel for HPV market​ represents a specialized but rapidly evolving segment within women’s healthcare, driven by increasing HPV awareness and the growing preference for non-invasive therapeutic options. With cervical cancer​ remaining a leading cause of cancer-related deaths among women worldwide (particularly in developing regions) and HPV infection being identified as the primary causative agent, the demand for effective topical treatments has surged significantly. While comprehensive market data specific to HPV vaginal gels is still emerging, the broader global gynecological therapies market​ is projected to exceed $60 billion by 2030, with topical formulations gaining substantial market share due to their…